Magdalena is a writer with a passion for bridging the gap between the people performing research, and those who want or need to understand it. She writes about medical science and drug discovery. She holds an MS in Pharmaceutical Bioscience and a PhD — spanning the fields of psychiatry, immunology, and neuropharmacology — from Karolinska Institutet in Sweden.
A compound that can silence a gene in a very specific manner was adapted by researchers to be used inside mitochondria — opening the possibility of manipulating genes linked to mitochondrial ... Read more
Tecfidera (dimethyl fumarate), an oral drug used to treat multiple sclerosis (MS), could also benefit mitochondrial disease patients as well as those with Friedreich’s ataxia (FA), concludes two studies from the ... Read more
A mitochondria-targeting compound called mitochonic acid (MA-5) had beneficial effects on mitochondrial function, energy production, and the formation of oxidative molecules in experiments involving a mouse model of mitochondrial ... Read more
Researchers discovered a new mutation in the mitochondrial genome with disease-causing potential when screening potential patients for new mitochondrial mutations. The study, “A novel MTTT mutation m.15933G > A ... Read more
A noninvasive method for analyzing the effectiveness of mitochondrial energy production in individual muscle groups shows promise to improve assessments in people with mitochondrial disease. Researchers hope the new ... Read more
Advanced biochemical engineering solutions have aided researchers in obtaining new knowledge about how mitochondria control programmed cell death, a self-destruction mechanism used by damaged or old cells. In the ... Read more